Metasphere Labs Inc.
LABZ
CNSX
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 141.52% | -60.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 99.89% | -55.67% | |||
| Operating Income | -144.21% | 63.71% | |||
| Income Before Tax | -91.46% | 63.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -91.46% | 63.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -91.46% | 63.69% | |||
| EBIT | -144.21% | 63.71% | |||
| EBITDA | -153.64% | 65.15% | |||
| EPS Basic | -100.00% | 67.80% | |||
| Normalized Basic EPS | -100.00% | 67.57% | |||
| EPS Diluted | -268.42% | 73.97% | |||
| Normalized Diluted EPS | -100.00% | 67.57% | |||
| Average Basic Shares Outstanding | -4.60% | 12.69% | |||
| Average Diluted Shares Outstanding | -4.60% | 12.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||